Colzyx


Colzyx AB is a company specializing in advanced biologic wound healing matrices, aiming to redefine wound care with a nature-inspired approach that harnesses the human body's own healing mechanisms. Their innovations focus on improving global health, cost-effectiveness, and quality of life through their products and technology.

Industries

biotechnology
cosmetics
fashion
health-care
medical

Nr. of Employees

small (1-50)

Colzyx

Lund, Skane Lan, Sweden, Europe


Products

Human biologic wound matrix

A biologic matrix product developed for treatment of human wounds, intended to accelerate healing and reduce infection.

Veterinary biologic wound matrix

A biologic wound-care product developed for veterinary use to support healing in animals.

Peptide-based wound-healing technology

Platform of peptides used as core technology for enhancing wound healing and related biological effects.


Services

Research and development collaborations

Collaborative R&D agreements with academic and industry partners to advance biomaterial and peptide technologies for wound care.

Grant-funded project management

Administration and execution of projects supported by public research funding, including EU Horizon 2020/EIC awards.

Expertise Areas

  • Wound-healing biomaterials
  • Peptide therapeutics for wound care
  • Antimicrobial biomaterials
  • Preclinical and translational research
  • Show More (3)

Key Technologies

  • Collagen-based biologic matrices
  • Peptide therapeutic platforms
  • Antimicrobial biomaterials
  • Biomaterial formulation for wound repair
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.